These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18590959)

  • 1. Discovery of novel and potent aryl diamines as leukotriene A4 hydrolase inhibitors.
    Khim SK; Bauman J; Evans J; Freeman B; King B; Kirkland T; Kochanny M; Lentz D; Liang A; Mendoza L; Phillips G; Tseng JL; Wei RG; Ye H; Yu L; Parkinson J; Guilford WJ
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3895-8. PubMed ID: 18590959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of N-alkyl glycine amides as potent inhibitors of leukotriene A4 hydrolase.
    Ye B; Bauman J; Chen M; Davey D; Khim SK; King B; Kirkland T; Kochanny M; Liang A; Lentz D; May K; Mendoza L; Phillips G; Selchau V; Schlyer S; Tseng JL; Wei RG; Ye H; Parkinson J; Guilford WJ
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3891-4. PubMed ID: 18586492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation and inhibition of leukotriene A4 hydrolase aminopeptidase activity by diphenyl ether and derivatives.
    Jiang X; Zhou L; Wei D; Meng H; Liu Y; Lai L
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6549-52. PubMed ID: 18952425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and optimization of N3,N6-diaryl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamines as a novel class of ACK1 inhibitors.
    Kopecky DJ; Hao X; Chen Y; Fu J; Jiao X; Jaen JC; Cardozo MG; Liu J; Wang Z; Walker NP; Wesche H; Li S; Farrelly E; Xiao SH; Kayser F
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6352-6. PubMed ID: 18993068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and evaluation of non-urea inhibitors of soluble epoxide hydrolase.
    Pecic S; Deng SX; Morisseau C; Hammock BD; Landry DW
    Bioorg Med Chem Lett; 2012 Jan; 22(1):601-5. PubMed ID: 22079754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel leukotriene A4 hydrolase inhibitors based on piperidine and piperazine scaffolds.
    Sandanayaka V; Mamat B; Bhagat N; Bedell L; Halldorsdottir G; Sigthorsdottir H; Andrésson T; Kiselyov A; Gurney M; Singh J
    Bioorg Med Chem Lett; 2010 May; 20(9):2851-4. PubMed ID: 20371179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of N-mercaptoacylproline and N-mercaptoacylthiazolidine-4-carboxylic acid derivatives as leukotriene A4 hydrolase inhibitors.
    Enomoto H; Morikawa Y; Miyake Y; Tsuji F; Mizuchi M; Suhara H; Fujimura K; Horiuchi M; Ban M
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4529-32. PubMed ID: 18674901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and SAR of conformationally restricted inhibitors of soluble epoxide hydrolase.
    Jones PD; Tsai HJ; Do ZN; Morisseau C; Hammock BD
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5212-6. PubMed ID: 16870439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
    Grice CA; Tays KL; Savall BM; Wei J; Butler CR; Axe FU; Bembenek SD; Fourie AM; Dunford PJ; Lundeen K; Coles F; Xue X; Riley JP; Williams KN; Karlsson L; Edwards JP
    J Med Chem; 2008 Jul; 51(14):4150-69. PubMed ID: 18588282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of dual target inhibitors against cyclooxygenases and leukotriene A4 hydrolyase.
    Chen Z; Wu Y; Liu Y; Yang S; Chen Y; Lai L
    J Med Chem; 2011 May; 54(10):3650-60. PubMed ID: 21542630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unsymmetrical non-adamantyl N,N'-diaryl urea and amide inhibitors of soluble expoxide hydrolase.
    Anandan SK; Webb HK; Do ZN; Gless RD
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4259-63. PubMed ID: 19520575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of imidazopyridines and purines as potent inhibitors of leukotriene A4 hydrolase.
    Penning TD; Chandrakumar NS; Desai BN; Djuric SW; Gasiecki AF; Malecha JW; Miyashiro JM; Russell MA; Askonas LJ; Gierse JK; Harding EI; Highkin MK; Kachur JF; Kim SH; Villani-Price D; Pyla EY; Ghoreishi-Haack NS; Smith WG
    Bioorg Med Chem Lett; 2003 Mar; 13(6):1137-9. PubMed ID: 12643929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrrolidine and piperidine analogues of SC-57461A as potent, orally active inhibitors of leukotriene A(4) hydrolase.
    Penning TD; Chandrakumar NS; Desai BN; Djuric SW; Gasiecki AF; Liang CD; Miyashiro JM; Russell MA; Askonas LJ; Gierse JK; Harding EI; Highkin MK; Kachur JF; Kim SH; Villani-Price D; Pyla EY; Ghoreishi-Haack NS; Smith WG
    Bioorg Med Chem Lett; 2002 Dec; 12(23):3383-6. PubMed ID: 12419366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of substituted nicotinamides as inhibitors of soluble epoxide hydrolase.
    Taylor SJ; Soleymanzadeh F; Eldrup AB; Farrow NA; Muegge I; Kukulka A; Kabcenell AK; De Lombaert S
    Bioorg Med Chem Lett; 2009 Oct; 19(20):5864-8. PubMed ID: 19758802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of recent drug discovery approaches for new generation leukotriene A4 hydrolase inhibitors.
    Calışkan B; Banoglu E
    Expert Opin Drug Discov; 2013 Jan; 8(1):49-63. PubMed ID: 23095029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermodynamic properties of leukotriene A
    Wittmann SK; Kalinowsky L; Kramer JS; Bloecher R; Knapp S; Steinhilber D; Pogoryelov D; Proschak E; Heering J
    Bioorg Med Chem; 2016 Nov; 24(21):5243-5248. PubMed ID: 27651294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The identification of pyrazolo[1,5-a]pyridines as potent p38 kinase inhibitors.
    Cheung M; Harris PA; Badiang JG; Peckham GE; Chamberlain SD; Alberti MJ; Jung DK; Harris SS; Bramson NH; Epperly AH; Stimpson SA; Peel MR
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5428-30. PubMed ID: 18818075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azabenzthiazole inhibitors of leukotriene A₄ hydrolase.
    Tanis VM; Bacani GM; Blevitt JM; Chrovian CC; Crawford S; De Leon A; Fourie AM; Gomez L; Grice CA; Herman K; Kearney AM; Landry-Bayle AM; Lee-Dutra A; Nelson J; Riley JP; Santillán A; Wiener JJ; Xue X; Young AL
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7504-11. PubMed ID: 23127888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salicylate-urea-based soluble epoxide hydrolase inhibitors with high metabolic and chemical stabilities.
    Kasagami T; Kim IH; Tsai HJ; Nishi K; Hammock BD; Morisseau C
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1784-9. PubMed ID: 19216074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of selective tight-binding inhibitors of leukotriene A4 hydrolase.
    Yuan W; Munoz B; Wong CH; Haeggström JZ; Wetterholm A; Samuelsson B
    J Med Chem; 1993 Jan; 36(2):211-20. PubMed ID: 8423594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.